Orange Book product · Generic (ANDA)
DOXYCYCLINE
DOXYCYCLINE
At a glance
Jan 21, 2021
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 21, 2021
5 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXYCYCLINE
Strength
EQ 50MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 208942
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXYCYCLINE
- 2006ORACEABrand (NDA)
NDA 050805 · GALDERMA LABS LP
- 1992MONODOXBrand (NDA)
NDA 050641 · CHARTWELL RX
- —VIBRAMYCINBrand (NDA)
NDA 050006 · PFIZER
- 2025DOXYCYCLINEGeneric (ANDA)
ANDA 219978 · AIPING PHARM INC
- 2025DOXYCYCLINEGeneric (ANDA)
ANDA 210381 · MACLEODS PHARMS LTD
- 2025DOXYCYCLINEGeneric (ANDA)
ANDA 217098 · PRINSTON INC
- 2024DOXYCYCLINEGeneric (ANDA)
ANDA 217170 · APOTEX
- 2024DOXYCYCLINEGeneric (ANDA)
ANDA 217674 · ALEMBIC
- 2024DOXYCYCLINEGeneric (ANDA)
ANDA 218034 · DR REDDYS
- 2024DOXYCYCLINEGeneric (ANDA)
ANDA 216631 · LUPIN
- 2017DOXYCYCLINEGeneric (ANDA)
ANDA 209396 · DR REDDYS LABS SA
- 2017DOXYCYCLINEGeneric (ANDA)
ANDA 209582 · ZYDUS PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
